Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Frances Ashcroft has been presented with the top award in this year’s L’ORÉAL-UNESCO For Women in Science programme.

She was one of five women scientists from around the world – one from each continent – named as 2012 Laureates at the annual award ceremony in Paris.
 
The $100,000 award recognises Professor Ashcroft’s work in advancing understanding of insulin secretion and a type of diabetes that develops in the first months of life.
 
Professor Ashcroft is a Royal Society Research Professor at the University of Oxford and a Fellow of Trinity College Oxford.
 
She said: ‘This award honours not only myself but also the team of dedicated scientists and collaborators with whom I have worked. I have been enormously fortunate: there is nothing more exciting or more rewarding than discovering something new.’
 
In 1984, Professor Ashcroft discovered the missing link connecting an increase in the blood sugar level, as happens after you eat a chocolate bar for example, to secretion of the hormone insulin. If this process fails, it leads to diabetes.
 
In subsequent studies, she unravelled how genetic mutations in this protein cause a rare inherited condition, known as neonatal diabetes, in which patients develop diabetes soon after birth. This has enabled many people with neonatal diabetes to switch to a better form of medication.

Professor Gunter Blobel, president of the award jury and the winner of the Nobel Prize in Physiology or Medicine in 1999, said: ‘This award is testament to Professor Ashcroft's intellectual achievements and her energy, dedication and passion for her research. The judges were also struck by her commitment to communicating science to the general public. She is an inspirational role model for younger female scientists.’
 
The For Women in Science Programme is run by the L’Oréal Corporate Foundation and UNESCO. The programme names five laureates each year, one from each continent, to recognise the groundbreaking achievements of leading female scientists.

Similar stories

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

MRC HIU appoints new Director

Awards and Appointments General

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

New Year's Honours 2021

Awards and Appointments General

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards and Appointments General

Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

Awards and Appointments General

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.